These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24247130)

  • 1. Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus.
    Valour F; Karsenty J; Bouaziz A; Ader F; Tod M; Lustig S; Laurent F; Ecochard R; Chidiac C; Ferry T;
    Antimicrob Agents Chemother; 2014; 58(2):746-55. PubMed ID: 24247130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort study.
    Valour F; Bouaziz A; Karsenty J; Ader F; Lustig S; Laurent F; Chidiac C; Ferry T;
    BMC Infect Dis; 2014 Aug; 14():443. PubMed ID: 25128919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
    Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
    BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.
    Bonnaire A; Vernet-Garnier V; Lebrun D; Bajolet O; Bonnet M; Hentzien M; Ohl X; Diallo S; Bani-Sadr F
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115225. PubMed ID: 33099073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-associated, methicillin-susceptible, and methicillin-resistant Staphylococcus aureus bone and joint infections in children: experience from India.
    Kini AR; Shetty V; Kumar AM; Shetty SM; Shetty A
    J Pediatr Orthop B; 2013 Mar; 22(2):158-66. PubMed ID: 23249998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monomicrobial bone and joint infection due to Corynebacterium striatum: literature review and amoxicillin-rifampin combination as treatment perspective.
    Noussair L; Salomon E; El Sayed F; Duran C; Bouchand F; Roux AL; Gaillard JL; Bauer T; Rottman M; Dinh A
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1269-1278. PubMed ID: 30903537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
    Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A
    Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS).
    Timbrook TT; McKay L; Sutton JD; Spivak ES
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and risk factors of Staphylococcus aureus CC398 bone and joint infections.
    Bouiller K; Hocquet D; Sauget M; Bertrand X; Chirouze C
    BMC Infect Dis; 2020 May; 20(1):384. PubMed ID: 32471442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible
    Chan L; Chan-Tompkins NH; Como J; Guarascio AJ
    Ann Pharmacother; 2020 Jul; 54(7):662-668. PubMed ID: 31888347
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study.
    Lecomte R; Bourreau A; Deschanvres C; Issa N; Le Turnier P; Gaborit B; Chauveau M; Leroy AG; Le Tourneau T; Caillon J; Camou F; Boutoille D
    Clin Microbiol Infect; 2021 Jul; 27(7):1015-1021. PubMed ID: 32950711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia.
    Rindone JP; Mellen CK
    Br J Clin Pharmacol; 2018 Jun; 84(6):1258-1266. PubMed ID: 29600576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypokalemia during antibiotic treatment for bone and joint infections.
    Falcone C; Compostella L; Camardo A; Truong LVS; Centofanti F
    Eur J Orthop Surg Traumatol; 2018 Apr; 28(3):389-395. PubMed ID: 29018986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pristinamycin in the treatment of MSSA bone and joint infection.
    Valour F; Boibieux A; Karsenty J; Vallat MP; Braun E; Perpoint T; Biron F; Laurent F; Lustig S; Chidiac C; Ferry T;
    J Antimicrob Chemother; 2016 Apr; 71(4):1063-70. PubMed ID: 26801082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.
    Senneville E; Joulie D; Legout L; Valette M; Dezèque H; Beltrand E; Roselé B; d'Escrivan T; Loïez C; Caillaux M; Yazdanpanah Y; Maynou C; Migaud H
    Clin Infect Dis; 2011 Aug; 53(4):334-40. PubMed ID: 21810745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.
    Lora-Tamayo J; Murillo O; Iribarren JA; Soriano A; Sánchez-Somolinos M; Baraia-Etxaburu JM; Rico A; Palomino J; Rodríguez-Pardo D; Horcajada JP; Benito N; Bahamonde A; Granados A; del Toro MD; Cobo J; Riera M; Ramos A; Jover-Sáenz A; Ariza J;
    Clin Infect Dis; 2013 Jan; 56(2):182-94. PubMed ID: 22942204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis.
    Al-Nammari SS; Bobak P; Venkatesh R
    Arch Orthop Trauma Surg; 2007 Sep; 127(7):537-42. PubMed ID: 17260151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France.
    Tonnelier M; Bouras A; Joseph C; Samad YE; Brunschweiler B; Schmit JL; Mabille C; Lanoix JP
    BMC Infect Dis; 2021 Feb; 21(1):174. PubMed ID: 33579208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-compliance with IDSA guidelines for patients presenting with methicillin-susceptible Staphylococcus aureus prosthetic joint infection is a risk factor for treatment failure.
    Bouaziz A; Uçkay I; Lustig S; Boibieux A; Lew D; Hoffmeyer P; Neyret P; Chidiac C; Ferry T
    Med Mal Infect; 2018 May; 48(3):207-211. PubMed ID: 29122410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Dosing of Cephalexin for Oral Step-Down Therapy of Pediatric Osteoarticular Infections Caused by Methicillin-Sensitive Staphylococcus Aureus.
    Ramchandar N; Arnold J; Cannavino C; Bradley JS
    Pediatr Infect Dis J; 2020 Jun; 39(6):523-525. PubMed ID: 32398570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.